Dezerv

Fund Overview

Fund Size

Fund Size

₹279 Cr

Expense Ratio

Expense Ratio

0.68%

ISIN

ISIN

INF966L01CD0

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

18 Jul 2023

About this fund

quant Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by Quant Mutual Fund. This fund has been in existence for 10 months, having been launched on 18-Jul-23.
As of 17-May-24, it has a Net Asset Value (NAV) of ₹14.04, Assets Under Management (AUM) of 279.47 Crores, and an expense ratio of 0.68%.
  • quant Healthcare Fund Direct Growth has given a CAGR return of 40.32% since inception.
  • The fund's asset allocation comprises around 98.90% in equities, 0.00% in debts, and 1.10% in cash & cash equivalents.
  • You can start investing in quant Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

+40.32%

(Cat Avg.)

Portfolio Summaryas of 30th April 2024

Equity276.41 Cr98.90%
Others3.07 Cr1.10%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Reliance Industries LtdEquity26.22 Cr9.38%
Aurobindo Pharma LtdEquity25.78 Cr9.22%
Poly Medicure LtdEquity24.46 Cr8.75%
Life Insurance Corporation of IndiaEquity23.97 Cr8.58%
GlaxoSmithKline Pharmaceuticals LtdEquity22.12 Cr7.91%
Indraprastha Medical Corp LtdEquity17.93 Cr6.41%
Jubilant Pharmova LtdEquity16.86 Cr6.03%
Kovai Medical Center & Hospital LtdEquity16.49 Cr5.90%
Gujarat Themis Biosyn LtdEquity13.34 Cr4.77%
Dishman Carbogen Amics LtdEquity13 Cr4.65%
SMS Pharmaceuticals LtdEquity12.3 Cr4.40%
Sequent Scientific LtdEquity11.98 Cr4.29%
Indoco Remedies LtdEquity10.47 Cr3.75%
Suven Life Sciences LtdEquity9.17 Cr3.28%
Granules India LtdEquity8.89 Cr3.18%
Aarti Pharmalabs LtdEquity8.25 Cr2.95%
AstraZeneca Pharma India LtdEquity6.2 Cr2.22%
Brooks Laboratories LtdEquity5.07 Cr1.81%
91 DTB 02052024Bond - Gov't/Treasury5 Cr1.79%
Kopran LtdEquity3.92 Cr1.40%
Nca-Net Current AssetsCash-3.09 Cr1.10%
Treps 02-May-2024 Depo 10Cash - Repurchase Agreement1.15 Cr0.41%

Allocation By Market Cap (Equity)

Large Cap Stocks

17.96%

Mid Cap Stocks

17.14%

Small Cap Stocks

63.81%

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare226.23 Cr80.95%
Energy26.22 Cr9.38%
Financial Services23.97 Cr8.58%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

14.57%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.69

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.16

Higher the better

Fund Managers

Sanjeev Sharma

Sanjeev Sharma

Since July 2023

VS

Vasav Sahgal

Since July 2023

AA

Ankit A. Pande

Since July 2023

ST

Sandeep Tandon

Since July 2023

Additional Scheme Detailsas of 30th April 2024

ISININF966L01CD0Expense Ratio0.68%Exit Load1.00%Fund Size₹279 CrAge18 Jul 2023Lumpsum Minimum₹5,000Fund StatusOpen Ended Investment CompanyBenchmarkS&P BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹13.07 Cr54.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹694.50 Cr57.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹694.50 Cr55.3%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹36.50 Cr52.9%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹161.86 Cr48.4%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹161.86 Cr45.4%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2236.01 Cr52.1%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2236.01 Cr49.9%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹639.49 Cr53.9%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹16.41 Cr51.7%

About the AMC

Total AUM

₹68,337 Cr

Address

A.M. Road, Prabhadevi, Mumbai, 400025

Other Funds by Quant Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
Quant Commodities Fund Direct Growth

Very High Risk

0.8%1.0%₹342.88 Cr-
Quant Momentum Fund Direct Growth

Very High Risk

0.7%1.0%₹1654.55 Cr-
Quantum Small Cap Fund Direct Growth

Very High Risk

0.6%0.0%₹47.23 Cr-
Quant Teck Fund Direct Growth

Very High Risk

0.8%1.0%₹350.04 Cr-
360 ONE Quant Fund Direct Growth

Very High Risk

0.4%1.0%₹175.14 Cr63.1%
Quant Value Fund Direct Growth

Very High Risk

0.5%1.0%₹1613.09 Cr75.4%
Nippon India Quant Fund Direct Growth

Very High Risk

0.5%0.0%₹63.00 Cr45.2%
Quant BFSI Fund Direct Growth

Very High Risk

0.7%1.0%₹513.60 Cr-
quant Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹279.47 Cr-
DSP Quant Fund Direct Growth

Very High Risk

0.6%0.0%₹1179.23 Cr21.8%
ICICI Prudential Quant Fund Direct Growth

Very High Risk

0.6%1.0%₹76.80 Cr36.6%
Axis Quant Fund Direct Growth

Very High Risk

0.7%1.0%₹1062.73 Cr38.6%
Quant Quantamental Fund Direct Growth

Very High Risk

0.6%1.0%₹2173.52 Cr67.0%
Tata Quant Fund Direct Growth

Very High Risk

0.9%1.0%₹57.67 Cr30.9%
Quant Focused fund Direct Growth

Very High Risk

0.7%1.0%₹924.73 Cr52.8%
Quant Large and Mid Cap Fund Direct Growth

Very High Risk

0.7%1.0%₹2535.89 Cr68.0%
Quant Active Fund Direct Growth

Very High Risk

0.6%1.0%₹9790.64 Cr53.2%
Quant Small Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹20164.09 Cr67.4%
Quant Absolute Fund Direct Growth

Very High Risk

0.8%1.0%₹2024.53 Cr39.1%
Quant Infrastructure Fund Direct Growth

Very High Risk

0.7%0.0%₹3187.60 Cr80.6%
Quant Multi Asset Fund Direct Growth

Very High Risk

0.7%1.0%₹2173.05 Cr49.2%
Quant Flexi Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹5562.88 Cr59.4%
Quant Tax Plan Direct Growth

Very High Risk

0.8%0.0%₹9360.89 Cr60.6%
Quant Liquid Plan Direct Growth

Low to Moderate Risk

0.3%0.0%₹2395.82 Cr7.2%
Quant Mid Cap Fund Direct Growth

Very High Risk

0.6%0.0%₹6920.17 Cr77.9%
Quant Gilt Fund Direct Growth

Moderate Risk

0.5%0.0%₹83.19 Cr6.5%
Quant Manufacturing Fund Direct Growth

Very High Risk

0.8%1.0%₹651.73 Cr-
Quant Business Cycle Fund Direct Growth

Very High Risk

0.6%1.0%₹1236.83 Cr-
Quant ESG Equity Fund Direct Growth

Very High Risk

0.8%1.0%₹253.71 Cr49.8%
Quant Overnight Fund Direct Growth

Low Risk

0.2%0.0%₹226.10 Cr7.3%
Quant Large Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹997.49 Cr52.8%
Quant Dynamic Asset Allocation Fund Direct Growth

Very High Risk

0.7%1.0%₹1046.84 Cr61.0%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of quant Healthcare Fund Direct Growth, as of 17-May-2024, is ₹14.04.
The fund's allocation of assets is distributed as 98.90% in equities, 0.00% in bonds, and 1.10% in cash and cash equivalents.
The fund managers responsible for quant Healthcare Fund Direct Growth are:-
  1. Sanjeev Sharma
  2. Vasav Sahgal
  3. Ankit A. Pande
  4. Sandeep Tandon